Wainscoat JS - Search Results

1

Telomere length in myelodysplastic syndromes.

Boultwood J, Fidler C, Kusec R, Rack K, Elliott PJ, Atoyebi O, Chapman R, Oscier DG, Wainscoat JS. Boultwood J, et al. Among authors: wainscoat js. Am J Hematol. 1997 Dec;56(4):266-71. doi: 10.1002/(sici)1096-8652(199712)56:4<266::aid-ajh12>3.0.co;2-7. Am J Hematol. 1997. PMID: 9395190 Free article.

2

Clonality in the myelodysplastic syndromes.

Boultwood J, Wainscoat JS. Boultwood J, et al. Among authors: wainscoat js. Int J Hematol. 2001 Jun;73(4):411-415. doi: 10.1007/BF02994002. Int J Hematol. 2001. PMID: 11503954 Review.

3

Gene expression profiling in the myelodysplastic syndromes.

Pellagatti A, Fidler C, Wainscoat JS, Boultwood J. Pellagatti A, et al. Among authors: wainscoat js. Hematology. 2005 Aug;10(4):281-7. doi: 10.1080/10245330500065680. Hematology. 2005. PMID: 16085540 Review.

4

Structure of the granulocyte macrophage colony-stimulating factor gene in patients with the myelodysplastic syndromes.

Boultwood J, Abrahamson G, Buckle VJ, Rack K, Oscier DG, Wainscoat JS. Boultwood J, et al. Among authors: wainscoat js. Am J Hematol. 1990 Jun;34(2):157-8. doi: 10.1002/ajh.2830340215. Am J Hematol. 1990. PMID: 2187337

5

Absence of immunoglobulin and T-cell receptor gene rearrangements in myelodysplastic syndromes and acute nonlymphocytic leukemias.

Wainscoat JS, Fey MF, Pilkington S, Summers C, Oscier DG. Wainscoat JS, et al. Am J Hematol. 1988 Jun;28(2):95-7. doi: 10.1002/ajh.2830280206. Am J Hematol. 1988. PMID: 3293439

6

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.

Lewis S, Oscier D, Boultwood J, Ross F, Fitchett M, Rack K, Abrahamson G, Buckle V, Wainscoat JS. Lewis S, et al. Among authors: wainscoat js. Am J Hematol. 1995 Jul;49(3):194-200. doi: 10.1002/ajh.2830490304. Am J Hematol. 1995. PMID: 7604812

7

Comparison of cytogenetic and restriction fragment length polymorphism analyses for the detection of loss of chromosome material in clonal hemopoietic disorders.

Abrahamson GM, Rack K, Oscier DG, Fitchett M, Buckle VJ, Wainscoat JS. Abrahamson GM, et al. Among authors: wainscoat js. Am J Hematol. 1993 Feb;42(2):171-6. doi: 10.1002/ajh.2830420206. Am J Hematol. 1993. PMID: 8094942

8

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.

Boultwood J, Fidler C, Shepherd P, Watkins F, Snowball J, Haynes S, Kusec R, Gaiger A, Littlewood TJ, Peniket AJ, Wainscoat JS. Boultwood J, et al. Among authors: wainscoat js. Am J Hematol. 1999 May;61(1):5-9. doi: 10.1002/(sici)1096-8652(199905)61:1<5::aid-ajh2>3.0.co;2-4. Am J Hematol. 1999. PMID: 10331504 Free article.

9

Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.

Boultwood J, Peniket A, Watkins F, Shepherd P, McGale P, Richards S, Fidler C, Littlewood TJ, Wainscoat JS. Boultwood J, et al. Among authors: wainscoat js. Blood. 2000 Jul 1;96(1):358-61. Blood. 2000. PMID: 10891474 Free article. Clinical Trial.

10

Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses.

Abrahamson G, Boultwood J, Madden J, Kelly S, Oscier DG, Rack K, Buckle VJ, Wainscoat JS. Abrahamson G, et al. Among authors: wainscoat js. Br J Haematol. 1991 Dec;79(4):550-5. doi: 10.1111/j.1365-2141.1991.tb08080.x. Br J Haematol. 1991. PMID: 1685326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page